These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21974743)

  • 1. Quantitative structure-activity relationships and docking studies of calcitonin gene-related peptide antagonists.
    Kyani A; Mehrabian M; Jenssen H
    Chem Biol Drug Des; 2012 Feb; 79(2):166-76. PubMed ID: 21974743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
    Robinson SD; Aitken JF; Bailey RJ; Poyner DR; Hay DL
    J Pharmacol Exp Ther; 2009 Nov; 331(2):513-21. PubMed ID: 19644039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin gene-related peptide analogues with aza and indolizidinone amino acid residues reveal conformational requirements for antagonist activity at the human calcitonin gene-related peptide 1 receptor.
    Boeglin D; Hamdan FF; Melendez RE; Cluzeau J; Laperriere A; Héroux M; Bouvier M; Lubell WD
    J Med Chem; 2007 Mar; 50(6):1401-8. PubMed ID: 17319653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat.
    Edvinsson L; Eftekhari S; Salvatore CA; Warfvinge K
    Mol Cell Neurosci; 2011 Jan; 46(1):333-9. PubMed ID: 21040789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative structure-activity relationship (QSAR) study of interleukin-1 receptor associated kinase 4 (IRAK-4) inhibitor activity by the genetic algorithm and multiple linear regression (GA-MLR) method.
    Pourbasheer E; Riahi S; Ganjali MR; Norouzi P
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):844-53. PubMed ID: 20429783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors.
    Qi T; Ly K; Poyner DR; Christopoulos G; Sexton PM; Hay DL
    Peptides; 2011 May; 32(5):1060-7. PubMed ID: 21402116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the key residue of calcitonin gene related peptide (CGRP) 27-37 to obtain antagonists with picomolar affinity at the CGRP receptor.
    Lang M; De Pol S; Baldauf C; Hofmann HJ; Reiser O; Beck-Sickinger AG
    J Med Chem; 2006 Jan; 49(2):616-24. PubMed ID: 16420047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-peptide calcitonin gene-related peptide receptor antagonists from a benzodiazepinone lead.
    Williams TM; Stump CA; Nguyen DN; Quigley AG; Bell IM; Gallicchio SN; Zartman CB; Wan BL; Penna KD; Kunapuli P; Kane SA; Koblan KS; Mosser SD; Rutledge RZ; Salvatore C; Fay JF; Vacca JP; Graham SL
    Bioorg Med Chem Lett; 2006 May; 16(10):2595-8. PubMed ID: 16527483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First pharmacophore model of CCR3 receptor antagonists and its homology model-assisted, stepwise virtual screening.
    Jain V; Saravanan P; Arvind A; Mohan CG
    Chem Biol Drug Des; 2011 May; 77(5):373-87. PubMed ID: 21284830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative structure-activity relationship and classification analysis of diaryl ureas against vascular endothelial growth factor receptor-2 kinase using linear and non-linear models.
    Sun M; Chen J; Wei H; Yin S; Yang Y; Ji M
    Chem Biol Drug Des; 2009 Jun; 73(6):644-54. PubMed ID: 19635056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneously optimized support vector regression combined with genetic algorithm for QSAR analysis of KDR/VEGFR-2 inhibitors.
    Sun M; Chen J; Cai J; Cao M; Yin S; Ji M
    Chem Biol Drug Des; 2010 May; 75(5):494-505. PubMed ID: 20486936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of novel alpha-Calcitonin Gene-Related Peptide (CGRP) receptor peptide antagonists that are selective for human CGRP receptors.
    Taylor CK; Smith DD; Hulce M; Abel PW
    J Pharmacol Exp Ther; 2006 Nov; 319(2):749-57. PubMed ID: 16873605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of azepanone calcitonin gene-related peptide (CGRP) receptor antagonists: development of novel spiropiperidines.
    Burgey CS; Potteiger CM; Deng JZ; Mosser SD; Salvatore CA; Yu S; Roller S; Kane SA; Vacca JP; Williams TM
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6368-72. PubMed ID: 19818613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitonin gene-related peptide receptor antagonists: new therapeutic agents for migraine.
    Bell IM
    J Med Chem; 2014 Oct; 57(19):7838-58. PubMed ID: 24960305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refolding and characterization of a soluble ectodomain complex of the calcitonin gene-related peptide receptor.
    Koth CM; Abdul-Manan N; Lepre CA; Connolly PJ; Yoo S; Mohanty AK; Lippke JA; Zwahlen J; Coll JT; Doran JD; Garcia-Guzman M; Moore JM
    Biochemistry; 2010 Mar; 49(9):1862-72. PubMed ID: 20099900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the human calcitonin gene-related peptide 1 receptor.
    Rist B; Entzeroth M; Beck-Sickinger AG
    J Med Chem; 1998 Jan; 41(1):117-23. PubMed ID: 9438028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical explanation of peptide binding to HLA-A*0201 major histocompatibility complex: a three-dimensional quantitative structure-activity relationship study.
    Doytchinova IA; Flower DR
    Proteins; 2002 Aug; 48(3):505-18. PubMed ID: 12112675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-Quantitative structure-activity relationship and docking studies of the tachykinin NK3 receptor.
    Geldenhuys WJ; Simmons MA
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7405-11. PubMed ID: 22056747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling of histamine H3 receptor and QSAR studies on arylbenzofuran derived H3 antagonists.
    Dastmalchi S; Hamzeh-Mivehroud M; Ghafourian T; Hamzeiy H
    J Mol Graph Model; 2008 Jan; 26(5):834-44. PubMed ID: 17561422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
    Bhunia SS; Roy KK; Saxena AK
    J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.